Hepatobiliary Disease in Clinical Practice: Update XX


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Hepatobiliary Disease in Clinical Practice: Update XX

  1. 1. Hepatobiliary Disease in Clinical Practice: Update XX February 22-23, 2013 Ritz-Carlton Coconut Grove Miami, FloridaCOURSE DIRECTOR:Eugene R. Schiff, MD, MACP,FRCP, MACG, AGAFHighlighted topics:• Interferon-Free Combination DAAs for HCV• HCV Antiviral Therapy for the Liver Transplant Patient• Promising Therapy for NASH• Ablative Therapies for HCCREGISTRATION AND INFORMATION:www.cme.med.miami.eduSPONSORED BY:University of Miami Miller School of MedicinePrEsented by:Schiff Center for Liver DiseasesDivision of Hepatology
  2. 2. OVERVIEW ACCREDITATIONJoin us for an informative, two-day, conference designed The University of Miami Leonard M. Miller School ofto present an update of knowledge in the diagnosis and Medicine is accredited by the ACCME to provide continuingmanagement of liver and biliary disease. National and medical education for physicians.international experts are scheduled to present a broadrange of topics. Didactic presentations will be augmentedwith audiovisuals, panel discussions and instructive casepresentations. CREDIT DESIGNATIONThe goal of this educational activity is to provide attendees The University of Miami Leonard M. Miller School ofwith improved competency, performance and quality of Medicine designates this educational activity for a maximumcare for patients. of 11.0 AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.TARGET AUDIENCEThis course is directed towards gastroenterologists andhepatologists. It will also be of interest to internists, infectious DISCLOSURE AND CONFLICTdisease specialists, alimentary tract surgeons and other OF INTEREST RESOLUTIONphysicians, residents, nurses and allied health professionals All conflicts of interest of any individual(s) in a position towho deal with these complex patients and issues. control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.OBJECTIVESAt the completion of the course, attendees will be able to:• Outline the value of IL 28B in therapeutic strategies for HCV• Examine the pros and cons of treating immunotolerant HBV patients who are generally not treated based on international guidelines• Tailor the treatment of non-alcoholic steatohepatitis for specific patients to maximize therapeutic success• Diagnose and treat patients with minimal encephalopathy, often an entity unrecognized and may be the basis for some auto accidents• Recognize the indication for Nanoknife ablation for HCC• Determine the risk and benefit of using early intervention with TIPS for bleeding esophageal varices• Compare the risk versus benefits of treating chronic hepatitis C patients with the currently available triple therapy• Anticipate the “test and treat” approach for chronic hepatitis C with implementation of CDC screening recommendations and the availability of interferon-free DAA combination therapy• Outline the complexity of drug-drug interaction when treating recurrent hepatitis C in liver transplant recipients• Utilize HBsAg liters to predict HBsAg seroconversion, a better indicator for sustained remission off of therapy• Examine the beneficial aspects of using statins in patients with liver disease• Recognize the spectrum of hepatic consequences of congestive heart failure REGISTER TODAY• Outline the different types of porphyria and how to effectively manage these patients Online at: www.cme.med.miami.edu By Fax: 305-243-5613
  3. 3. Hepatobiliary Disease in Clinical Practice: Update XX February 22-23, 2013 COURSE DIRECTOR Stuart C. Gordon, MD Mark Sulkowski, MD Director, Division of Hepatology Professor of Medicine Eugene R. Schiff, MD, MACP, Henry Ford Health Systems Medical Director FRCP, MACG, AGAF Professor of Medicine Viral Hepatitis Center Leonard Miller Professor of Medicine Wayne State University Johns Hopkins University Dr. Nasser Ibrahim Al-Rashid Chair in School of Medicine School of Medicine the Division of Hepatology, University Detroit, Michigan Baltimore, MD of Miami Center for Liver Diseases Director, Schiff Center Stephen A. Harrison, MD, FACP Norah A. Terrault, MD, MPH for Liver Diseases LTC(P), MC, USA Professor of Clinical Director, Hepatology Research Chief, Hepatology Medicine and Surgery Laboratory Gastroenterology Service Departments of Medicine and Surgery Miami, FL Professor of Medicine, Uniformed Director of Viral Hepatitis Services University for the Research in Liver Transplantation Health Sciences Program Director University of California, San Francisco GUEST FACULTY Gastroenterology Fellowship Program San Francisco, CA SAMMC Consultant to The Surgeon Jasmohan S. Bajaj, MBBS, MD, MS General for Gastroenterological Diseases Brooke Army Medical Center UHEALTH/UNIVERSITY OF Assistant Professor of Medicine San Antonio Military Medical Center MIAMI MILLER SCHOOL OF Division of Gastroenterology San Antonio, TX MEDICINE FACULTY Hepatology and Nutrition Virginia Commonwealth University Kalyan R. Bhamidimarri, MD Kris V. Kowdley, MD, FACP, FACG, FGA McGuire VA Medical Center Director of the Liver Center of Assistant Professor of Richmond, VA Excellence in the Digestive Clinical Hepatology Disease Institute Division of Hepatology Joseph Bloomer, MD Virginia Mason Medical Center Professor of Medicine Clinical Professor of Medicine Lennox J. Jeffers, MD, FACP Director, University of Alabama University of Washington Professor of Medicine Liver Center Seattle, WA Chief, Hepatology Section University of Alabama Department of Veterans School of Medicine Edward L. Krawitt, MD Affairs Medical Center Birmingham, AL Professor Emeritus University of Vermont Cynthia Levy, MD Thomas Boyer, MD Adjunct Professor Associate Professor of Medicine Professor of Medicine Dartmouth Medical School Division of Hepatology Director, Liver Research Institute Burlington, VT Chair, Department of Medicine Paul Martin, MD, FACP University of Arizona James H. Lewis, MD, FACP, FACG Professor of Medicine College of Medicine Professor and Director of Hepatology Chief, Division of Hepatology Tucson, AZ Division of Gastroenterology Georgetown University Raj Narayanan, MD Mark L. Brantly, MD Medical Center Chief of Vascular and Professor of Medicine and Chief Washington, DC Interventional Radiology Molecular Genetics and Microbiology Associate Professor of Alpha One Foundation Anna S. F. Lok, MD, FRCP Clinical Radiology Research Professor Professor, Department of Department of Radiology Division of Pulmonary Internal Medicine Critical Care and Sleep Medicine Alice Lohrman Andrews Research Christopher B. O’Brien, MD University of Florida Professor in Hepatology Professor of Medicine College of Medicine Director, Clinical Hepatology Chief of Clinical Hepatology Gainesville, FL Associate Chair for Clinical Research Division of Hepatology Department of Internal Medicine Douglas Dietrich, MD University of Michigan Adam Peyton, DO Professor of Medicine Ann Arbor, MI Assistant Professor Division of Liver Diseases Division of Hepatology Director of Continuing Robert P. Perrillo, MD Department of Veterans Medical Education Director of the Transplant Hepatology Affairs Medical Center Department of Medicine Fellowship Program Mount Sinai School of Medicine Baylor University Medical Center New York, NY Dallas, TX
  4. 4. Program Agenda February 22-23, 2013Friday , Fe bruary 2 2 , 2 0 1 3 11:30-12:45 pm Instructive Cases – Panel Moderator: Eugene R. Schiff, MD7:30-8:25 am Registration and Panelists: Continental Breakfast Mark Sulkowski, MD Norah A. Terrault, MD, MPH Robert O. Perrillo, MD8:25-8:30 am Opening Remarks Steve Harrison, MD and Welcome James H. Lewis, MD Eugene R. Schiff, MD 12:45-2:00 pm LunchModerator: Paul Martin, MD Moderator: Christopher O’Brien, MD8:30-9:00 am Interferon- Free Combination DAAs for HCV Mark Sulkowski, MD 2:00-2:30 pm The Liver in Congestive Heart Failure Stuart C. Gordon, MD9:00-9:30 am HCV Antiviral Therapy for the Liver Transplant Patient Norah A. Terrault, MD, MPH 2:30-3:00 pm Ablative Therapies for HCC Raj Narayanan, MD9:30-10:00 am Tailoring Treatment for the 3:00-3:30 pm Refreshment Break Chronic Hepatitis B Patient Robert O. Perrillo, MD 3:30-4:00 pm Who gets What for Portal Hypertension10:00-10:30 am Refreshment Break Thomas Boyer, MDModerator: Lennox Jeffers, MD Moderator: Kalyan Bhamidmari, MD10:30-11:00 am Promising Therapy for NASH 4:00-4:30 pm The Spectrum of Porphyria Stephen Harrison, MD Joseph Bloomer, MD11:00-11:30 am Drug-Induced Liver Disease: 4:30-5:00 pm Prevention of Reactive Do Statins Prevent HCC Hepatitis B in Patients on in Cirrhotics? Immunosuppressive Therapy James H. Lewis, MD Anna S. F. Lok, MD
  5. 5. Perioperative Medicine Summit February 5-7, 20105:00-6:00 pm Instructive Cases – Panel 11:00-11:30 am Co-Infection HBV & HCV with HIV Moderator: Douglas Dieterich, MD Eugene R. Schiff, MD Panelist: Stuart Gordon, MD 11:30-12:45 pm Instructive Cases – Panel Raj Narayanan, MD Moderator: Thomas Boyer, MD Eugene R. Schiff, MD Joseph Bloomer, MD Anna Lok, MD Panelists: Kris V. Kowdley, MD Edward Krawitt, MD6:00 PM Adjourn/Free time Jasmohan S. Bajaj, MBBS, MD, MS Mark L. Brantly, MD Douglas Dieterich, MDSaturday , F eb ruary 23, 2013 12:45 pm Evaluations/Adjourn8:00-8:30 am Registration and Continental BreakfastModerator: Cynthia Levy, MD8:30-9:00 am Management of Sclerosing Cholangitis Kris V. Kowdley, MD9:00-9:30 am Management of Autoimmune Overlap Syndromes Edward Krawitt, MD9:30-10:00 Management of Hepatic Encephalopathy Jasmohan Bajaj, MD10:00-10:30 Refreshment BreakModerator: Adam Peyton, MD10:30-11:00 am Recognizing Alpha-1-Antitrypsin Deficiency in Patients with Liver Disease Mark L. Brantly, MD
  6. 6. Hepatobiliary Disease inClinical Practice: Update XXHOTEL INFORMATION:Ritz-Carlton Coconut Grove3300 SW 27 AvenueMiami, FL 33133Toll-free: 1-800-241-3333http://www.ritzcarlton.com/en/Properties/CoconutGrove/Default.htmSPECIAL CONFERENCE RATE:A block of rooms has been reserved forconference participants at a discounted rateof US $309/night + 13% tax/day. The rate isguaranteed only until January 23, 2013 . Thehotel extends the group rate 3 days pre andpost conference dates based on availability.After January 23, 2013 , reservation requests Ritz-Carlton Coconut Grovewill be considered on a space-available basis. All reservations should beRESERVATIONS: received by the hotel no later thanCall 1-800-241-3333 and reference UM January 23, 2013. All individual reservationsHepatobiliary Conference. Individual must be accompanied by a first night roomguest room reservations may also be deposit or guaranteed with a major creditmade on the hotel’s reservations page: card. Hotel will not hold any reservationshttp://www.ritzcarlton.com/en/Properties/ unless secured by one of the above methods.CoconutGrove/Default.htm. Miami CME Winter Series 2013 The Miami CME Winter Series 2013 is sponsored by the University of Miami Miller School of Medicine and UHealth, the University of Miami Health System. UHealth/Miller embodies the best in academic medicine, with more than 2,000 scientists and clinicians seeking cures and introducing new care protocols. We are committed to sharing our knowledge through exceptional CME programming. 3rd Annual Therapeutic 8th Annual Perioperative Synergy 2013, A Hypothermia and Tempera- Medicine Summit 2013 Multidisciplinary Approach ture Management 2013 March 7-9, 2013 to Interventional Oncology March 4-5, 2013 Eden Roc Hotel October 25-27, 2013 Miami Biscayne Bay Marriott Miami Beach, Florida Fontainebleau Miami Beach Miami, Florida Miami Beach, Florida REGISTER TODAY AT www.cme.med.miami.edu
  7. 7. Hepatobiliary Disease in Clinical Practice: Update XX February 22-23, 2013 REGISTRATION FORM To register, please visit www.cme.med.miami.edu or complete this form and mail or fax (with payment) to: University of Miami Miller School of Medicine Division of CME (D23-3) P.O. Box 016960 Miami, FL 33101-6960 Telephone: 305-243-6716 Fax: 305-243-5613 First Name __________________________ Last Name _______________________ Degree (MD, DO, PhD, ARNP, etc.) __________________ Affiliation _____________________________________________________________________________________________________________ Specialty:_________________________________________ Last 4 digits of SSN#:________________ (for CME recording / identification purposes only) Mailing Address _______________________________________________________________________________________________________ City: __________________________________________________________ State _______________ Zip/Postal Code ___________________ Daytime Telephone ____________________ Fax: ___________________ Email: (mandatory)   _________________________________________ Before As of TUITION: 1/25/2013 1/25/2013 Onsite  Physicians $500 $545 $595  Nurses/Nurse Practitioners $400 $425 $475  Physician Assistants $400 $425 $475  Allied Healthcare Professionals/Other $400 $425 $475  UM/JMH Fellows and Residents $0 $0 $0 PAYMENT METHOD:  Check: Please make check payable to UM/Division of CME  Charge my registration fee in the amount of $ _______________ to my:  Visa®  MasterCard®  American Express Card Number _______________________________________________________ Expiration Date ____________________________________ How did you hear about this program?  Brochure  Email  Colleague  Flyer/Announcement  Website  Other _________________________________________ REGISTRATION CANCELLATION POLICY Refunds will be made only if written notice of cancellation is received prior to January 25, 2013. A $100 fee is charged for all refunds. After this date, no refunds will be made. In cases where a course is cancelled due to insufficient registrations, a full tuition refund will be made. SERVICES FOR THE DISABLED Please contact the Division of CME prior to February 1, 2013 should you have any special needs that may require additional assistance. A conference staff member will contact you to discuss these special requirements. FOR MORE INFORMATION, CONTACT Division of Continuing Medical Education Tel: 305-243-6716 /Fax: 305-243-5613 umcme@med.miami.edu
  8. 8. NON-PROFIT ORGANIZATION US PostageUniversity of Miami Miller School of Medicine PAIDDivision of Continuing Medical Education Miami, FLP.O. Box 016960 (D23-3) Permit No. 438Miami, FL 33101-6960Hepatobiliary Disease inClinical Practice: Update XXFebruary 22-23, 2013Ritz-Carlton Coconut GroveMiami, FloridaREGISTER TODAY ATwww.cme.med.miami.edu Hepatobiliary Disease in Clinical Practice: Update XX February 22-23, 2013 Ritz-Carlton Coconut Grove Miami, Florida COURSE DIRECTOR: Eugene R. Schiff, MD, ACP, FRCP, MACG, AGAF SPONSORED BY: University of Miami Miller School of Medicine PrEsented by: Schiff Center for Liver Diseases Division of Hepatology REGISTRATION AND INFORMATION: www.cme.med.miami.edu